ABAB Pedia

Chitra Kotwaliwale

Chitra Kotwaliwale is a product executive trained in cell biology. She worked as a computational biologist at Adaptive Biotechnologies before moving into product roles at Complete Genomics and Agilent Technologies. She joined Natera in 2019 and later became its chief product officer.

Contents6 sections
Key facts

Early education: Biology and cell research

Kotwaliwale earned a bachelor’s degree in biology at the College of Wooster. She subsequently earned her doctorate in molecular and cell biology through the University of Washington and Fred Hutchinson Cancer Center.⁠[1]

Postdoctoral research at Berkeley and industry roles

Her postdoctoral work at UC BerkeleyUniversity of California, BerkeleyThe University of California, Berkeley (UC Berkeley) is a campus of the University of California system; the University of California was founded in 1868 through a merger of two institutions and moved to Berkeley, California, in 1873.Open the full entry received support from the Damon Runyon Cancer Research Foundation and the Howard Hughes Medical Institute. The foundation’s awards register gives her name as Chitra V. Kotwaliwale and dates her award to 2008. She went on to work as a computational biologist at Adaptive Biotechnologies, senior product manager for sequencing at Complete Genomics and director of product marketing at Agilent Technologies, managing a team responsible for rare disease and oncology products.⁠[1][2]

Product leadership at Natera

Kotwaliwale joined Natera in 2019. She managed products in its women’s health business, coordinated company strategy and project planning across engineering and research, and worked on global product strategy. Her title at the time of her 2024 interview was senior vice president of portfolio management and operations. She later became chief product officer.⁠[1][3]

Discussing resource allocation

On Crucible Moments, Kotwaliwale explained that Natera’s established women’s health business still needed to reduce testing costs while it invested in oncology. Choosing how much to devote to existing products and new ones was a continuing problem. To illustrate growth, she estimated that Signatera processed only a few thousand samples in all of 2019, compared with more than 100,000 in the first quarter of 2024 alone.⁠[3][4]

Related Organizations, Websites and Public Accounts

Natera: Chief product officer. Official website: https://www.natera.com/ (opens in a new window).⁠[1]

Sources5 sources

  1. Leadership Team: Matthew Rabinowitz, Ph.D. (opens in a new window)natera.com↑
  2. Damon Runyon Cancer Research Foundation Awardees, K–P (opens in a new window)damonrunyon.org↑
  3. Natera ft. Matthew Rabinowitz: A Personal Mission That Led to a Biotech Revolution (opens in a new window)sequoiacap.com↑
  4. Natera ft. Matthew Rabinowitz - A Personal Mission That Led to a Biotech Revolution (opens in a new window)youtube.com↑
  5. Chitra Kotwaliwale, Ph.D. (opens in a new window)linkedin.com↑